NEW DELHI: Today, 24th Feb, The Supreme Court of India strongly addressed the issue of misleading advertisements in the medical field, particularly those targeting allopathic medicine. The Court is hearing a plea filed by the Indian Medical Association (IMA) against such deceptive ads and has stressed the importance of following Rule 170 of the Drugs and Cosmetics Rules, 1945.
In response to the RG Kar rape-murder case, the father of the victim commended the ‘Droher Carnival’ organized by junior doctors, calling it a “victory for doctors” and a sign of resilience. This event coincided with protests against police restrictions and ongoing demands for justice, garnering national support from the Indian Medical Association.
The Supreme Court today directed the Indian Medical Association (IMA) to ensure the removal of misleading advertisements by Patanjali Ayurved. It particularly targets 14 products whose licenses were revoked. The court appointed an amicus curiae and instructed the licensing authority to submit an affidavit regarding the licensing process. IMA president issued an unconditional apology.
Today, On 31st May, Goa has become the first Indian state to fully implement “Living Will” advanced medical directives, empowering individuals to outline medical treatment preferences in advance. The initiative aims to give patients more control over end-of-life care decisions and reduce the burden on families and healthcare providers. The recent event in Panji marked the unveiling of the Advanced Medical Directives (AMD) booklet and the first living will signed by Justice MS Sonak. This milestone sets a new precedent in end-of-life care in India.
NEW DELHI: Today (10th April): The Supreme Court has rejected Patanjali’s unconditional apology for misleading advertisements, criticizing the company for deliberate disobedience. Justices Hima Kohli and Ahsanuddin Amanullah emphasized that leniency would not be shown. Patanjali founders acknowledged the breach, but the court disapproved, asserting the seriousness of the matter. The case pertains to false advertisements for Patanjali’s medicinal products.
